Breaking News, Collaborations & Alliances

Scimega, Q-CROC in Biomarkers Research Alliance

Will work to identify predictive biomarkers in drug-resistant tumors

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Scimega Research has been selected by the Quebec – Clinical Research Organization in Cancer (Q-CROC) to oversee the conduct of three studies to identify predictive biomarkers in drug-resistant tumors.   In February 2013, the Minister of Finance and the Economy, and the Minister for Industrial Policy, and the Quebec Economic Development Bank, Élaine Zakaïb, invested $10 million in the Personalized Medicine Partnership for Cancer (PMPC), a public-private partnership for implementation of personali...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters